These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
169 related articles for article (PubMed ID: 31765781)
1. Taste-masking and colloidal-stable cubosomes loaded with Cefpodoxime proxetil for pediatric oral delivery. Fan Y; Chen H; Huang Z; Zhu J; Wan F; Peng T; Pan X; Huang Y; Wu C Int J Pharm; 2020 Feb; 575():118875. PubMed ID: 31765781 [TBL] [Abstract][Full Text] [Related]
2. Self-nanoemulsifying drug delivery system of cefpodoxime proxetil containing tocopherol polyethylene glycol succinate. Bajaj A; Rao MR; Khole I; Munjapara G Drug Dev Ind Pharm; 2013 May; 39(5):635-45. PubMed ID: 22564007 [TBL] [Abstract][Full Text] [Related]
3. Design and evaluation of self-nanoemulsifying drug delivery systems (SNEDDS) for cefpodoxime proxetil. Date AA; Nagarsenker MS Int J Pharm; 2007 Feb; 329(1-2):166-72. PubMed ID: 17010543 [TBL] [Abstract][Full Text] [Related]
4. Development and characterization of lyophilized cefpodoxime proxetil-Pluronic Yurtdaş-Kırımlıoğlu G Pharm Dev Technol; 2021 Apr; 26(4):476-489. PubMed ID: 33616480 [TBL] [Abstract][Full Text] [Related]
6. Validated HPLC method for the pharmacokinetic study of oral extended-release cefpodoxime proxetil chitosan-alginate beads in rabbits. Mujtaba A; Kohli K Int J Biol Macromol; 2017 May; 98():111-116. PubMed ID: 28137463 [TBL] [Abstract][Full Text] [Related]
7. Multiparticulate system combining taste masking and immediate release properties for the aversive compound praziquantel. Münster M; Schoch C; Schmidt C; Breitkreutz J Eur J Pharm Sci; 2017 Nov; 109():446-454. PubMed ID: 28887230 [TBL] [Abstract][Full Text] [Related]
8. In vitro/in vivo evaluation of HPMC/alginate based extended-release matrix tablets of cefpodoxime proxetil. Mujtaba A; Kohli K Int J Biol Macromol; 2016 Aug; 89():434-41. PubMed ID: 27155235 [TBL] [Abstract][Full Text] [Related]
9. A novel glyceryl monoolein-bearing cubosomes for gambogenic acid: Preparation, cytotoxicity and intracellular uptake. Luo Q; Lin T; Zhang CY; Zhu T; Wang L; Ji Z; Jia B; Ge T; Peng D; Chen W Int J Pharm; 2015 Sep; 493(1-2):30-9. PubMed ID: 26209071 [TBL] [Abstract][Full Text] [Related]
10. Monoolein-based nanoparticles containing indinavir: a taste-masked drug delivery system. Bianchin MD; Prebianca G; Immich MF; Teixeira ML; Colombo M; Koester LS; Araújo BV; Poletto F; Külkamp-Guerreiro IC Drug Dev Ind Pharm; 2021 Jan; 47(1):83-91. PubMed ID: 33289591 [TBL] [Abstract][Full Text] [Related]
11. Enhancement of bioavailability of cefpodoxime proxetil using different polymeric microparticles. Khan F; Katara R; Ramteke S AAPS PharmSciTech; 2010 Sep; 11(3):1368-75. PubMed ID: 20821175 [TBL] [Abstract][Full Text] [Related]
12. Preparation & characterization of solid inclusion complex of cefpodoxime proxetil with beta-cyclodextrin. Bhargava S; Agrawal GP Curr Drug Deliv; 2008 Jan; 5(1):1-6. PubMed ID: 18220545 [TBL] [Abstract][Full Text] [Related]
13. Silica nanoparticle stabilization of liquid crystalline lipid dispersions: impact on enzymatic digestion and drug solubilization. Bhatt AB; Barnes TJ; Prestidge CA Curr Drug Deliv; 2015; 12(1):47-55. PubMed ID: 25176029 [TBL] [Abstract][Full Text] [Related]
14. Investigation on physicochemical and biological differences of cefpodoxime proxetil enantiomers. Kakumanu VK; Arora V; Bansal AK Eur J Pharm Biopharm; 2006 Oct; 64(2):255-9. PubMed ID: 16797950 [TBL] [Abstract][Full Text] [Related]
15. Influence of drug-carrier compatibility and preparation method on the properties of paclitaxel-loaded lipid liquid crystalline nanoparticles. Wu H; Cui Z; Huo Y; Sun Y; Zhang X; Guan J; Mao S J Pharm Sci; 2021 Jul; 110(7):2800-2807. PubMed ID: 33785353 [TBL] [Abstract][Full Text] [Related]